Dap-ug, Jellfe E.
HRN: 22-12-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
CEFUROXIME 500MG (TAB)
11/27/2023
12/04/2023
PO
500mg
BID
SP CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes